Latest News about IBB
Recent news which mentions IBB
   Beat the market with this quant system that’s very bullish on stocks at record highs
   
  
  
  September 04, 2021
  From MarketWatch
 
   Cassava Sciences CEO says ‘enormous profit motive’ behind N.Y. law firm’s fraud allegations
   
  
  
  September 03, 2021
  From MarketWatch
 
   The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
   
  
  
  September 03, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
   
  
  
  September 02, 2021
  From Benzinga
 
   ETF Prime: Tom Lydon Talks Pros & Cons of Market Cap Weighting
   
  
  
  September 01, 2021
  From ETF Trends
 
   The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
   
  
  
  September 01, 2021
  From Benzinga
 From Benzinga
 From Benzinga
 
   The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
   
  
  
  August 29, 2021
  From Benzinga
 
   7 Best ETFs to Buy to Cover a Broad Spectrum of Opportunities
   
  
  
  August 27, 2021
  From InvestorPlace
 
   The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
   
  
  
  August 27, 2021
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
   
  
  
  August 22, 2021
  From Benzinga
 
   The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
   
  
  
  August 20, 2021
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
   
  
  
  August 15, 2021
  From Benzinga
 From Benzinga
 
   The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
   
  
  
  August 13, 2021
  From Benzinga
 From Benzinga
 
   The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
   
  
  
  August 11, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
   
  
  
  August 10, 2021
  From Benzinga
 
   Moderna Vaccine Is Granted Authorization in Australia
   
  
  
  August 09, 2021
  From ETF Trends
 
   Unusual Options Activity Insight: iShares Biotechnology ETF
   
  August 09, 2021
  Tickers 
   IBB
  
  
  From Benzinga
 
   3 Stocks to Buy for the Second Half of 2021
   
  
  
  August 09, 2021
  From InvestorPlace
 
   Carter Worth And Mike Khouw's XBI Trade
   
  
  
  August 08, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
